Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It is testing CONCERTA* vs.
Location not clearly listedThis study is completed. It is testing CONCERTA® (Methylphenidate Hydrochloride) for ADHD.
Location not clearly listed
This summary needs review. Please check the official study record and contact the research team for details.
In SpainThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ChicagoThis study is completed in Japan. It focuses on ADHD.
Multiple locations, including ChibaThis study is completed in Bulgaria, in Estonia, in Lithuania, .... It is testing 3 Fixed Doses of JNJ-37822681 for schizophrenia.
Multiple locations, including BurgasThis study is completed in the United States, in India, in Romania, .... It is testing Extended-Release (ER) Paliperidone for schizophrenia.
Multiple locations, including DothanThis study is completed in South Korea. It is testing long Acting Injectable Risperidone and Oral Risperidone for schizophrenia.
In AnsanThis study is completed in Taiwan. It is testing Long-acting Risperidone for schizophrenia.
In TaipeiThis study is completed in South Korea. It is testing Long-Term Risperidone Microspheres for schizophrenia.
In SeoulThis study is completed in the United States, in India, and in Taiwan. It is testing One Dosage of Paliperidone Extended Release (ER) for schizophrenia.
Multiple locations, including CerritosThis study is completed. It is testing osmotic Release Oral System Methylphenidate for ADHD.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.